4586 — Medrx Co Balance Sheet
0.000.00%
- ¥7bn
- ¥6bn
- ¥258m
Annual balance sheet for Medrx Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,812 | 1,704 | 994 | 1,721 | 1,978 |
| Net Total Receivables | 37.1 | 23 | 15.2 | 33 | 44.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,887 | 1,755 | 1,087 | 1,785 | 2,073 |
| Net Property, Plant And Equipment | 328 | 270 | 226 | 182 | 124 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,297 | 2,109 | 1,398 | 2,052 | 2,276 |
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 123 | 126 | 158 | 100 | 106 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 150 | 153 | 186 | 128 | 106 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 2,147 | 1,955 | 1,213 | 1,925 | 2,170 |
| Total Liabilities & Shareholders' Equity | 2,297 | 2,109 | 1,398 | 2,052 | 2,276 |
| Total Common Shares Outstanding |